These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 29930023
1. Association of Blood Pressure Measurements With Peripheral Artery Disease Events. Itoga NK, Tawfik DS, Lee CK, Maruyama S, Leeper NJ, Chang TI. Circulation; 2018 Oct 23; 138(17):1805-1814. PubMed ID: 29930023 [Abstract] [Full Text] [Related]
6. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. Piller LB, Simpson LM, Baraniuk S, Habib GB, Rahman M, Basile JN, Dart RA, Ellsworth AJ, Fendley H, Probstfield JL, Whelton PK, Davis BR, ALLHAT Collaborative Research Group. J Gen Intern Med; 2014 Nov 23; 29(11):1475-83. PubMed ID: 25002161 [Abstract] [Full Text] [Related]
7. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Böhm M, Schumacher H, Teo KK, Lonn E, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder R, Weber M, Sliwa K, Williams B, Yusuf S. Eur Heart J; 2018 Sep 01; 39(33):3105-3114. PubMed ID: 29873709 [Abstract] [Full Text] [Related]
8. Blood pressure targets in adults with hypertension. Arguedas JA, Leiva V, Wright JM. Cochrane Database Syst Rev; 2020 Dec 17; 12(12):CD004349. PubMed ID: 33332584 [Abstract] [Full Text] [Related]
9. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension. Yano Y, Rakugi H, Bakris GL, Lloyd-Jones DM, Oparil S, Saruta T, Shimada K, Matsuoka H, Imai Y, Ogihara T. Hypertension; 2017 Feb 17; 69(2):220-227. PubMed ID: 28049699 [Abstract] [Full Text] [Related]
10. J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm. Kalkman DN, Brouwer TF, Vehmeijer JT, Berger WR, Knops RE, de Winter RJ, Peters RJ, van den Born BH. Circulation; 2017 Dec 05; 136(23):2220-2229. PubMed ID: 28939617 [Abstract] [Full Text] [Related]
11. The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in women. Powell TM, Glynn RJ, Buring JE, Creager MA, Ridker PM, Pradhan AD. Vasc Med; 2011 Aug 05; 16(4):239-46. PubMed ID: 21730007 [Abstract] [Full Text] [Related]
12. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study. Johnson K, Oparil S, Davis BR, Tereshchenko LG. J Am Heart Assoc; 2019 Apr 16; 8(8):e011961. PubMed ID: 30943832 [Abstract] [Full Text] [Related]
13. Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial. Vrsalovic M, Heimark S, Søraas CL, Mehlum MH, Kjeldsen SE, Mancia G, Julius S, Weber MA. Hypertension; 2024 Jul 16; 81(7):1628-1636. PubMed ID: 38716657 [Abstract] [Full Text] [Related]
14. Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Dhruva SS, Huang C, Spatz ES, Coppi AC, Warner F, Li SX, Lin H, Xu X, Furberg CD, Davis BR, Pressel SL, Coifman RR, Krumholz HM. Hypertension; 2017 Jul 16; 70(1):94-102. PubMed ID: 28559399 [Abstract] [Full Text] [Related]
15. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA; 2002 Dec 18; 288(23):2981-97. PubMed ID: 12479763 [Abstract] [Full Text] [Related]
16. Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment. Lieb W, Enserro DM, Sullivan LM, Vasan RS. J Am Heart Assoc; 2015 Nov 20; 4(11):. PubMed ID: 26588944 [Abstract] [Full Text] [Related]
17. Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin. Navar AM, Gallup DS, Lokhnygina Y, Green JB, McGuire DK, Armstrong PW, Buse JB, Engel SS, Lachin JM, Standl E, Van de Werf F, Holman RR, Peterson ED, TECOS Study Group. Hypertension; 2017 Nov 20; 70(5):907-914. PubMed ID: 28847886 [Abstract] [Full Text] [Related]
18. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S, ALLHAT Collaborative Research Group. Circulation; 2008 Nov 25; 118(22):2259-67. PubMed ID: 19001024 [Abstract] [Full Text] [Related]
19. Optimal Target Blood Pressure and Risk of Cardiovascular Disease in Low-Risk Younger Hypertensive Patients. Kwon CH, Kang J, Cho A, Chang Y, Ryu S, Sung KC. Am J Hypertens; 2019 Aug 14; 32(9):833-841. PubMed ID: 31045225 [Abstract] [Full Text] [Related]
20. Target Blood Pressure in Patients with Diabetes: Asian Perspective. Park S, Kario K, Park CG, Huang QF, Cheng HM, Hoshide S, Wang JG, Chen CH, Characteristics On the ManagEment of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG). Yonsei Med J; 2016 Nov 14; 57(6):1307-11. PubMed ID: 27593856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]